Time may be running out on Ned Sharpless’ term as acting FDA commissioner. President Donald Trump must make a decision about the agency's top job by Nov. 1.
If the White House decides to seek Senate confirmation for Sharpless, he would have to step down as acting commissioner during the confirmation process. He could be appointed to a placeholder position at FDA for this period.
Alternatively, the administration could hand off the acting commissioner title to someone